Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis

Leukemia. 2014 Jan;28(1):225-7. doi: 10.1038/leu.2013.235. Epub 2013 Aug 9.

Authors

G Caocci¹, F Murgia², L Podda³, A Solinas⁴, S Atzeni², G La Nasa¹

Affiliations

¹ 1] Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy [2] Bone Marrow Transplant Center, R. Binaghi Hospital, Cagliari, Italy.
² Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.
³ Hematology Unit, University Hospital, Sassari, Italy.
⁴ Department of Biomedical Science, University of Sassari, Sassari, Italy.

PMID: 23929216
DOI: 10.1038/leu.2013.235

No abstract available

Publication types

Letter

MeSH terms

Hepatitis B / complications*
Humans
Janus Kinases / antagonists & inhibitors
Nitriles
Primary Myelofibrosis / complications*
Pyrazoles / therapeutic use*
Pyrimidines
Virus Activation*

Substances

Nitriles
Pyrazoles
Pyrimidines
ruxolitinib
Janus Kinases